On Friday, June 21, 2024, the FDA updated its Patent Listing Dispute List to indicate that the ten pharmaceutical companies who had received warning letters from the FTC in April did not make changes to their patent listings...more
In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit affirmed the district court’s decision granting Genentech’s motion for summary judgment that claims 1-4, 9, and 20 of U.S. Patent No. 7,033,590 (“the...more
SANOFI-AVENTIS U.S., LLC v. FRESENIUS KABI USA, LLC -
Before Lourie, Moore, and Taranto. Appeal from the United States District Court for the District of New Jersey.
Summary: District courts lack the authority to...more
8/20/2019
/ Article III ,
Inter Partes Review (IPR) Proceeding ,
Issue Preclusion ,
Motion to Amend ,
Obviousness ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Standing ,
Vacated
In 1992, the United States Court of Appeals for the Federal Circuit held that manufacturers of patented medical devices can use the patent laws to enforce single-use restrictions on medical devices. Mallinckrodt, Inc. v....more